Evidences suggest that BRCA1 part of the "Role of BRCA1, BRCA2 and ATR in Cancer Susceptibility" pathway significantly enhances the ability of TNF-α or IFN-γ to activate transcription from the promoters of NF-κB target genes. The gene discussed is IFNG; the disease is cancer.